CELEBRATE
Phase 1/2 Unknown
78 enrolled
CRLM-Z
Phase 1/2 Unknown
40 enrolled
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
Phase 1/2 Unknown
172 enrolled
MSCs for the Treatment of Burn Wounds
Phase 1/2 Unknown
50 enrolled
HLX301
Phase 1/2 Unknown
30 enrolled
A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
126 enrolled
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
Phase 1/2 Unknown
186 enrolled
SeliGIST
Phase 1/2 Unknown
30 enrolled
REGOMUNE
Phase 1/2 Unknown
747 enrolled
The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors
Phase 1/2 Unknown
115 enrolled
A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma
Phase 1/2 Unknown
96 enrolled
NeoPepVac
Phase 1/2 Unknown
12 enrolled
PULSE-UM
Phase 1/2 Unknown
16 enrolled
A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies
Phase 1/2 Unknown
164 enrolled
An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma
Phase 1/2 Unknown
10 enrolled
An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer
Phase 1/2 Unknown
50 enrolled
Microwave Ablation of Primary and Secondary Lung Malignancies
Phase 1/2 Unknown
35 enrolled
DEBOXA for Inoperable NET Liver Metastases
Phase 1/2 Unknown
60 enrolled
A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer
Phase 1/2 Unknown
106 enrolled
A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC
Phase 1/2 Unknown
20 enrolled
Anlotinib and Irinotecan for Ewing Sarcoma
Phase 1/2 Unknown
47 enrolled
PI-MMC
Phase 1/2 Unknown
30 enrolled
Evaluation of Viatarâ„¢ Oncopheresis System in Removing CTC From Whole Blood
Phase 1/2 Unknown
100 enrolled
ADSCs-BWs
Phase 1/2 Unknown
20 enrolled
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Phase 1/2 Unknown
50 enrolled
Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor
Phase 1/2 Unknown
62 enrolled
Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm
Phase 1/2 Unknown
Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Phase 1/2 Unknown
20 enrolled
GVAX in Advanced Prostate Cancer Patients Made Lymphopenic
Phase 1/2 Unknown
18 enrolled
A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer
Phase 1/2 Unknown
95 enrolled
Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma
Phase 1/2 Unknown
25 enrolled
Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen
Phase 1/2 Unknown
46 enrolled
Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies
Phase 1/2 Unknown
105 enrolled